Daily Trend Analysis Report On: (OTC:RHHBY), (Pink:NSRGY)
Roche Holding AG (OTC:RHHBY) and Isis Pharmaceuticals, Inc. (ISIS) announced, earlier this month, that they have formed an alliance to develop treatments for Huntington's disease (HD) based on Isis' antisense oligonucleotide (ASO) technology.
View full press release